Join the Special Session: NCI Funding for Research and Training

NCI at AACR 2020 WEDNESDAY, JUNE 24 As the American Association for Cancer Research (AACR) 2020 Virtual Annual Meeting comes to a close today, we encourage you to join us for these sessions from NCI experts. You can still register to view this live and on-demand content.

Today: Learn About NCI Funding and Training Opportunities Session: NCI Funding for Research and Training│ 1:45-2:55 p.m. EDT This session will feature four NCI experts who will provide an overview of NCI’s grant process, funding mechanisms, and training opportunities—such as fellowships, career development awards, and institutional training grants—to help attendees understand how NCI makes funding available to the research community and supports the development of the next generation of cancer researchers. Presenters: Dan Gallahan, Ph.D., Director, NCI Division of Cancer Biology Oliver Bogler, Ph.D., Director, Center for Cancer Training Tiffany A. Wallace, Ph.D., Program Director, Center to Reduce Cancer Health Disparities Julia T. Arnold, Ph.D., Program Director, Division of Cancer Treatment and Diagnosis AACR Honors NCI Cancer Researchers Patricia S. Steeg, PhD Co-director of the Office of Translational Resources and associate director of the Center for Cancer Research at the NCI, Dr. Patricia Steeg, will receive the 2020 AACR-Women in Cancer Research Charlotte Friend Memorial Lectureship. Dr. Steeg is being honored with this lectureship for her groundbreaking research on breast cancer metastasis. Join this session │ 12:00-12:45 p.m. (EDT) Steven A. Rosenberg, MD Chief of the Surgery Branch at NCI and senior investigator at the NCI Center for Cancer Research, Dr. Steven Rosenberg, is being honored with the 2020 AACR-CRI Lloyd J. Old Award in Cancer Immunology. This award recognizes Dr. Rosenberg’s pioneering discoveries in the field of cancer immunotherapy. Join this session │12:45-1:30 p.m. (EDT) The Cancer Genome Atlas Team The AACR is recognizing The Cancer Genome Atlas (TCGA) founding members and current project team with 2020 Team Science Awards, which will be presented during a Data Resources for Cancer Research session. Join this session | 4:00 p.m. (EDT) Attend Today’s Sessions Featuring NCI Speakers NCI’s cancer research experts are participating in sessions throughout Virtual Annual Meeting II. Be sure to check out the full list of conference abstracts for details and additional sessions.  All session times are U.S. EDT. Today’s Oral Presentations: Innovative Approaches and Tools to Study the Tumor Microenvironment Presentation: Intratumor regulatory T cells prevent IFN-gamma-dependent tumor vessel regression and can be selectively targeted by anti-CD25 near-infrared photoimmunotherapy 9:50 – 10:00 a.m. │ NCI Presenter: Yutaka Kurebayashi Infection and Immune Factors Presentations: Associations of anti-parietal cell and anti-intrinsic factor antibodies with gastric cancer risk and Elevated incidence of rare cancers among solid organ transplant recipients (SOTRs) in the United States 9:50 – 10:00 a.m. and 10:35 - 10:45 a.m.│ NCI Presenters: Jill Koshiol, Eric Engels, and Minkyo Song Novel Mechanisms: From Tumor Suppression to Identification of Novel Therapeutics Presentation: Epigenetic reactivation of the DLC1 tumor suppressor protein is a new approach for cancer treatment 10:20 – 10:30 a.m. │ NCI Presenter: Brajendra Tripathi Clinical Trial Design: Part 4: Trial Design for Early Cancer Detection Presentation: Biomarkers for early-phase cancer prevention/immunoprevention trials 4:00 – 4:20 p.m. │ NCI Presenter: Asad Umar Tomorrow's Special Presentation: NCI COVID-19 in Cancer Patients Study (NCCAPS) Thursday, June 25 at 1:00 p.m. NCI remains committed to our mission of cancer research and is working diligently to meet the needs of cancer patients during the COVID-19 pandemic. That’s why we launched a long-term, nationwide study, called NCI COVID-19 in Cancer Patients Study (NCCAPS). NCI invites you to participate in a virtual presentation where study coordinators will review the objectives of NCCAPS, with an opportunity for Q+A. Registration is free and open to the public. For more information about NCCAPS, check out the recent Cancer Currents blog post, by Dr. James Doroshow, "How Does COVID-19 Affect People with Cancer? NCCAPS Will Help Find Out" Connect with NCI For more information about NCI’s presentations and resources, be sure to visit our NCI at AACR webpage. To join the discussion, follow NCI on Twitter at @theNCI and Instagram at @nationalcancerinstitute.